SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-18-000050
Filing Date
2018-11-09
Accepted
2018-11-08 19:38:28
Documents
89
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20180930x10q.htm 10-Q 2780687
2 EX-31.1 amph-20180930ex311dba783.htm EX-31.1 22854
3 EX-31.2 amph-20180930ex31247552a.htm EX-31.2 22974
4 EX-32.1 amph-20180930ex321a7f118.htm EX-32.1 12340
5 EX-32.2 amph-20180930ex322c72ab5.htm EX-32.2 12309
  Complete submission text file 0001297184-18-000050.txt   10577559

Data Files

Seq Description Document Type Size
6 EX-101.INS amph-20180930.xml EX-101.INS 2703508
7 EX-101.SCH amph-20180930.xsd EX-101.SCH 63081
8 EX-101.CAL amph-20180930_cal.xml EX-101.CAL 54550
9 EX-101.DEF amph-20180930_def.xml EX-101.DEF 193288
10 EX-101.LAB amph-20180930_lab.xml EX-101.LAB 449999
11 EX-101.PRE amph-20180930_pre.xml EX-101.PRE 396115
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 181171110
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences